Cargando…
Clinical significance of CD28 gene‐related activating alterations in adult T‐cell leukaemia/lymphoma
Multiple oncogenic events are involved in the development of adult T‐cell leukaemia/lymphoma (ATL). Because CD28 plays a pivotal role in T‐cell activation, we focused on alterations of the CD28 gene in ATL. We found multiple genetic abnormalities related to CD28 among the 144 patients enrolled in th...
Autores principales: | Sakamoto, Yuma, Ishida, Takashi, Masaki, Ayako, Takeshita, Morishige, Iwasaki, Hiromi, Yonekura, Kentaro, Tashiro, Yukie, Ito, Asahi, Kusumoto, Shigeru, Utsunomiya, Atae, Iida, Shinsuke, Ueda, Ryuzo, Inagaki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894310/ https://www.ncbi.nlm.nih.gov/pubmed/33205842 http://dx.doi.org/10.1111/bjh.17211 |
Ejemplares similares
-
Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2021) -
Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2021) -
Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
por: Nosaka, Kisato, et al.
Publicado: (2021) -
CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment
por: Sakamoto, Yuma, et al.
Publicado: (2022) -
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
por: Ishida, Takashi, et al.
Publicado: (2015)